Pronađeno: 1-2 / 2 radova

Autori: Sierzega M

>> Filter: Samo Article i Review

>> Sve godine

Naslov Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Clinical, Safety and Biomarker Results From the FENopta Open-Label Extension (Meeting Abstract)
Autori Bar-Or Amit Oh J Dufek Michal Budincevic Hrvoje Habek Mario Caunt Maresa Harp C Sierzega M Clayton David Chen Y Ratchford JN Goodyear Alexandra Drulovic Jelena S  
Info MULTIPLE SCLEROSIS JOURNAL, (2025), vol. 31 br. 2_SUPPL, Suppl. 2_SUPPL, str. 244-244
Ispravka Web of Science   Elečas   Rang časopisa  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Efficacy and Safety of Fenebrutinib, a Noncovalent, Reversible BTK inhibitor, in MS: Primary Results of a Phase 2 Trial (Meeting Abstract)
Autori Hua Le Bar-Or Amit Weber Martin Habek Mario Budincevic Hrvoje Thomas Piia Napieralski Julie Ratchford John Qi Qi Sierzega M Drulovic Jelena S  
Info EUROPEAN JOURNAL OF NEUROLOGY, (2023), vol. 30 br. , Suppl. 1, str. -
Ispravka Web of Science   Elečas   Rang časopisa  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX